TUNIU CORP-SPON ADR (TOUR)
US89977P1066 - ADR
Taking everything into account, TOUR scores 2 out of 10 in our fundamental rating. TOUR was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of TOUR is average, but there are quite some concerns on its profitability. TOUR has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
TOUR had negative earnings in the past year.
TOUR had negative earnings in each of the past 5 years.
In the past 5 years TOUR reported 4 times negative operating cash flow.
1.2 Ratios
TOUR has a Return On Assets of 1.36%. This is comparable to the rest of the industry: TOUR outperforms 44.78% of its industry peers.
TOUR has a Return On Equity of 2.47%. This is comparable to the rest of the industry: TOUR outperforms 55.22% of its industry peers.
The Return On Invested Capital of TOUR (0.08%) is worse than 79.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.47% | ||
| ROIC | 0.08% |
ROA(3y)-18.84%
ROA(5y)-13.99%
ROE(3y)-40.5%
ROE(5y)-30.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of TOUR (7.78%) is better than 70.15% of its industry peers.
TOUR's Operating Margin of 0.33% is on the low side compared to the rest of the industry. TOUR is outperformed by 79.10% of its industry peers.
TOUR has a Gross Margin of 62.73%. This is in the better half of the industry: TOUR outperforms 72.39% of its industry peers.
TOUR's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.33% | ||
| PM (TTM) | 7.78% | ||
| GM | 62.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.06%
GM growth 5Y-1.7%
2. Health
2.1 Basic Checks
TOUR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TOUR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for TOUR remains at a similar level compared to 5 years ago.
The debt/assets ratio for TOUR has been reduced compared to a year ago.
2.2 Solvency
TOUR has an Altman-Z score of -4.24. This is a bad value and indicates that TOUR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -4.24, TOUR is not doing good in the industry: 94.78% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.01 indicates that TOUR is not too dependend on debt financing.
TOUR has a better Debt to Equity ratio (0.01) than 88.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.24 |
ROIC/WACC0.01
WACC7.95%
2.3 Liquidity
TOUR has a Current Ratio of 1.55. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TOUR (1.55) is better than 75.37% of its industry peers.
TOUR has a Quick Ratio of 1.55. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
TOUR's Quick ratio of 1.55 is fine compared to the rest of the industry. TOUR outperforms 77.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.55 |
3. Growth
3.1 Past
TOUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2200.00%.
The Revenue has been growing slightly by 1.83% in the past year.
The Revenue has been decreasing by -8.39% on average over the past years.
EPS 1Y (TTM)-2200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)1.83%
Revenue growth 3Y-39.94%
Revenue growth 5Y-8.39%
Sales Q2Q%65.04%
3.2 Future
Based on estimates for the next years, TOUR will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.33% on average per year.
Based on estimates for the next years, TOUR will show a very negative growth in Revenue. The Revenue will decrease by -25.51% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5Y17.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5Y-25.51%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
TOUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -37.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
TOUR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TUNIU CORP-SPON ADR
NASDAQ:TOUR (11/4/2024, 8:00:00 PM)
1.15
+0.03 (+2.77%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap135.76M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.47% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 0.33% | ||
| PM (TTM) | 7.78% | ||
| GM | 62.73% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-2200%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.83%
Revenue growth 3Y-39.94%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y